4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-24-025924
Options or other derivatives
- CEO acquired 0 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Pershing Edward · CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-06-26 | Grant or award : show line 1 in the form 8% Unsecured Convertible Promissory Note | +0 | D |
Loading xslF345X05/ownership.xml…